AETHLON MEDICAL INC | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Article By: Benzinga
Sunday, February 13, 2022 6:44 PM EDT
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings.
In this article: AZN, PFE, AEMD, NVAX, GILD, AGIO, BCDA, ATXI, MODD, TCBP
Read
S&P 500 Nabs Intraday Record Despite Disappointing Inflation Data
Article By: Schaeffers Research
Thursday, June 10, 2021 12:40 PM EDT
The major indexes are brushing off shaky inflation and jobless data this afternoon, with consumer prices growing at their fastest pace since the summer of 2008, while jobless claims came in above analysts' expectations.
In this article: IVR, AEMD, NDX, SPX, VIX, DJI, MDLY
Read
Benchmarks Edge Higher While "Meme" Stock Craze Continues
Article By: Schaeffers Research
Wednesday, June 9, 2021 12:30 PM EDT
Stocks are modestly higher at midday, once again falling just short of seemingly elusive record highs.
In this article: AEMD, UNFI, NDX, SPX, VIX, DJI, CLOV, WISH
Read
Stock Charts To Watch - Wednesday, Jan. 29
Video By: Harry Boxer
Wednesday, January 29, 2020 11:00 PM EDT
Aethlon Medical, Inc. has been in an explosive trend, literally going from 75 cents around the first of Jan to 4.00 currently, but you can see that the 2-day inside days might lead to another explosive move.
In this video: GE, AEMD, PENN, LB, CLSD
Watch
Stock Charts To Watch - Monday, Jan. 27
Video By: Harry Boxer
Monday, January 27, 2020 9:19 PM EDT
Aethlon Medical, Inc. has been exploding of late since the debacle started. This stock has gone, literally, from 76 cents to Monday’s high at 4.07, in the last five weeks.
In this video: APT, AEMD, NNVC, VIVO, CBLI, RLMD
Watch
All Posts

Latest Tweets for $AEMD

No tweets yet!

PARTNER HEADLINES